CORATTUR NATESAN: Open Payments
NPI 1790770568 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,449 in 47 payments from 18 companies in 2025. Trend: 2023 $1,015 · 2024 $1,177 · 2025 $1,449
Food & beverage: $1,449
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $352 |
| Olympus America Inc. | 2 | $309 |
| Dendreon Pharmaceuticals LLC | 1 | $144 |
| Novo Nordisk Inc | 8 | $141 |
| Aimmune Therapeutics, Inc. | 7 | $131 |
| Boston Scientific Corporation | 2 | $82 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| PFIZER INC. | 2 | $32 |
| ABBVIE INC. | 1 | $26 |
Products named: iTIND System, AIRSUPRA, PROVENGE, ZENPEP, WATCHMAN Access System, FARXIGA, LEQVIO, REXULTI.
Industry payments across OH — which companies pay providers there.
